Addus HomeCare (NASDAQ:ADUS) Given Neutral Rating at Bank of America

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “neutral” rating reiterated by equities researchers at Bank of America in a note issued to investors on Monday, Benzinga reports. They presently have a $125.00 price objective on the stock, down from their prior price objective of $140.00. Bank of America‘s price objective suggests a potential upside of 6.76% from the company’s previous close.

Several other research firms also recently issued reports on ADUS. Royal Bank Of Canada upped their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Barclays boosted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $128.38.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $117.09 on Monday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.19 billion, a PE ratio of 20.54, a P/E/G ratio of 1.57 and a beta of 0.86. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $124.43. The firm has a fifty day moving average price of $115.65 and a 200 day moving average price of $103.25.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the prior year, the company posted $1.49 EPS. The firm’s revenue was up 8.0% on a year-over-year basis. Analysts expect that Addus HomeCare will post 6.3 EPS for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Dixon sold 288 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Global Retirement Partners LLC lifted its holdings in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the period. Larson Financial Group LLC lifted its stake in Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. NFJ Investment Group LLC bought a new position in Addus HomeCare during the second quarter worth about $29,000. Acumen Wealth Advisors LLC acquired a new stake in Addus HomeCare during the fourth quarter valued at approximately $29,000. Finally, Arax Advisory Partners grew its stake in shares of Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults, people with disabilities and individuals with chronic or complex medical needs. The company operates through three primary service lines: personal care, hospice and home health.

Its personal care services include assistance with daily living activities, such as bathing, dressing, meal preparation and household tasks. Addus also provides hospice care for individuals with terminal illnesses, as well as home health services that may include skilled nursing, therapy and other clinical support.